Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.
about
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosisM-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.Force-induced Adrb2 in periodontal ligament cells promotes tooth movement.Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy.Introduction to the series: challenges and opportunities in pediatric heart failure and transplantation.Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment.Adrenergic signaling in heart failure: a balance of toxic and protective effects.Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.β 1 Adrenoceptor antagonistic effects of the supposedly selective β 2 adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts.Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy.The Molecular Apgar Score: A Key to Unlocking Evolutionary PrinciplesA New Pathway for Sympathetic Cardioprotection in Heart Failure.Stage‑dependent changes of β2‑adrenergic receptor signaling in right ventricular remodeling in monocrotaline‑induced pulmonary arterial hypertension.
P2860
Q28573405-3DEAB73A-055F-4192-90D3-5D17DE243D9FQ34381658-911D2872-7D6D-45BF-858C-57D875FC4DA2Q34494355-93DFCCCF-52ED-4E4F-B9E8-4A2FD07CC1C0Q34950408-69B0C18B-1AD6-4BCD-AF83-733B5B66846BQ36342091-3E6DB273-F22F-4975-8F9E-F10D9BDD100FQ37061259-36F8A3E7-70FC-4F61-94DB-0869DB8FA42AQ37486302-A42CCDCE-FB2C-4EA5-B656-49F85CC74D0AQ37742299-5EDDE25F-5543-4A80-A0FE-3988DD8AB877Q38195518-2C41A3D0-26A3-4C93-A45D-886FED850BBDQ38951165-2968A8E4-29A2-4CFB-AC6F-481B1174CDB9Q39263982-BA7C8BBE-E3ED-4EC5-AA51-1FA78BA64446Q41808403-7E2FF02D-7416-40BB-AF85-6E39619A7EC6Q41983421-E1A83727-8109-4834-9FEE-2B0E343746D5Q42315412-4A343DF6-3236-43C2-9D07-3280EA4863F6Q43115266-D4CEF6CB-673B-4B28-BF73-F01682E96A98Q47824028-5FC766FD-0A04-49D6-A9DA-E251E18B12B1
P2860
Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Deletion of the β2-adrenergic ...... ent of cardiomyopathy in mice.
@ast
Deletion of the β2-adrenergic ...... ent of cardiomyopathy in mice.
@en
type
label
Deletion of the β2-adrenergic ...... ent of cardiomyopathy in mice.
@ast
Deletion of the β2-adrenergic ...... ent of cardiomyopathy in mice.
@en
prefLabel
Deletion of the β2-adrenergic ...... ent of cardiomyopathy in mice.
@ast
Deletion of the β2-adrenergic ...... ent of cardiomyopathy in mice.
@en
P2093
P2860
P1476
Deletion of the β2-adrenergic ...... ent of cardiomyopathy in mice.
@en
P2093
Daniel Bernstein
Dong-Qing Hu
Giovanni Fajardo
Mingming Zhao
Sara Farahani
Sushma Reddy
Takashi Urashima
P2860
P304
P356
10.1016/J.YJMCC.2013.07.016
P577
2013-08-03T00:00:00Z